| Ventral tegmental area glutamate neurons co-release GABA and promote positive reinforcement JH Yoo, V Zell, N Gutierrez-Reed, J Wu, R Ressler, MA Shenasa, ... Nature communications 7 (1), 13697, 2016 | 193 | 2016 |
| Opponent control of behavioral reinforcement by inhibitory and excitatory projections from the ventral pallidum L Faget, V Zell, E Souter, A McPherson, R Ressler, N Gutierrez-Reed, ... Nature communications 9 (1), 849, 2018 | 155 | 2018 |
| VTA glutamate neuron activity drives positive reinforcement absent dopamine co-release V Zell, T Steinkellner, NG Hollon, SM Warlow, E Souter, L Faget, ... Neuron 107 (5), 864-873. e4, 2020 | 93 | 2020 |
| Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons T Steinkellner, V Zell, ZJ Farino, MS Sonders, M Villeneuve, RJ Freyberg, ... The Journal of clinical investigation 128 (2), 774-788, 2018 | 87 | 2018 |
| Causal role for the subthalamic nucleus in interrupting behavior KH Fife, NA Gutierrez-Reed, V Zell, J Bailly, CM Lewis, AR Aron, ... elife 6, e27689, 2017 | 85 | 2017 |
| Activation of pedunculopontine glutamate neurons is reinforcing JH Yoo, V Zell, J Wu, C Punta, N Ramajayam, X Shen, L Faget, ... Journal of Neuroscience 37 (1), 38-46, 2017 | 57 | 2017 |
| Disrupting glutamate co-transmission does not affect acquisition of conditioned behavior reinforced by dopamine neuron activation DV Wang, T Viereckel, V Zell, Å Konradsson-Geuken, CJ Broker, ... Cell reports 18 (11), 2584-2591, 2017 | 45 | 2017 |
| The NeuroD6 subtype of VTA neurons contributes to psychostimulant sensitization and behavioral reinforcement Z Bimpisidis, N König, S Stagkourakis, V Zell, B Vlcek, S Dumas, B Giros, ... Eneuro 6 (3), 2019 | 28 | 2019 |
| Peripheral and central alterations affecting spinal nociceptive processing and pain at adulthood in rats exposed to neonatal maternal deprivation PE Juif, C Salio, V Zell, M Melchior, A Lacaud, N Petit‐Demouliere, ... European Journal of Neuroscience 44 (3), 1952-1962, 2016 | 23 | 2016 |
| Etifoxine analgesia in experimental monoarthritis: a combined action that protects spinal inhibition and limits central inflammatory processes M Aouad, V Zell, PE Juif, A Lacaud, Y Goumon, P Darbon, V Lelievre, ... PAIN® 155 (2), 403-412, 2014 | 23 | 2014 |
| Corticosterone analgesia is mediated by the spinal production of neuroactive metabolites that enhance GABA ergic inhibitory transmission on dorsal horn rat neurons V Zell, PÉ Juif, U Hanesch, P Poisbeau, F Anton, P Darbon European Journal of Neuroscience 41 (3), 390-397, 2015 | 18 | 2015 |
| Disruption of VGLUT1 in cholinergic medial habenula projections increases nicotine self-administration EA Souter, YC Chen, V Zell, V Lallai, T Steinkellner, WS Conrad, ... Eneuro 9 (1), 2022 | 8 | 2022 |
| Genetic Probe for Visualizing Glutamatergic Synapses and Vesicles by 3D Electron Microscopy T Steinkellner, M Madany, MG Haberl, V Zell, C Li, J Hu, M Mackey, ... ACS chemical neuroscience 12 (4), 626-639, 2021 | 6 | 2021 |
| Plasma glucocorticoids differentially modulate phasic and tonic GABA inhibition during early postnatal development in rat spinal lamina II V Zell, U Hanesch, P Poisbeau, F Anton, P Darbon Neuroscience letters 578, 39-43, 2014 | 6 | 2014 |
| Mesoaccumbal glutamate neurons drive reward via glutamate release but aversion via dopamine co-release SM Warlow, SM Singhal, NG Hollon, L Faget, DS Dowlat, V Zell, ... Neuron 112 (3), 488-499. e5, 2024 | 5 | 2024 |
| Neurotensin receptor 1-biased ligand attenuates neurotensin-mediated excitation of ventral tegmental area dopamine neurons and dopamine release in the nucleus accumbens SM Singhal, V Zell, L Faget, LM Slosky, LS Barak, MG Caron, ... Neuropharmacology 234, 109544, 2023 | 2 | 2023 |
| Characterization of Selective M5 Acetylcholine Muscarinic Receptor Modulators on Dopamine Signaling in the Striatum V Zell, G Teuns, AS Needham, S Mukherjee, N Roscoe, M Le, ... Journal of Pharmacology and Experimental Therapeutics 387 (2), 226-234, 2023 | 1 | 2023 |
| iris-AperTO PE Juif, C Salio, V Zell, M Melchior, A Lacaud, N Petit-Demouliere, ... | | 2023 |
| Ex Vivo Pharmacological Characterization of Selective M5 Acetylcholine Muscarinic Receptor Modulators on Dopamine Release in the Mouse Striatum V Zell, P Bonaventure, G Woodruff, W Drevets, B Balana NEUROPSYCHOPHARMACOLOGY 46 (SUPPL 1), 251-251, 2021 | | 2021 |
| Role of Subthalamic Nucleus in Interrupting Behavior K Fife, J Heston, N Gutierrez-Reed, V Zell, J Bailly, C Lewis, A Aron, ... NEUROPSYCHOPHARMACOLOGY 43, S153-S153, 2017 | | 2017 |
Thomas HnaskoProfessor of Neurosciences; University of California, San DiegoVerified email at ucsd.edu
